Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics and pharmacoepidemiology.

J K Jones1

  • 1Degge Group, Ltd., Suite 1430, 1616 N. Ft. Myer Drive, Arlington, VA 22209, USA. jkjones@deggegroup.com

Pharmacoepidemiology and Drug Safety
|January 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications.

Scientific reports·2021
Same author

Channel waveguide laser at 1 microm in Yb-indiffused LiNbO(3).

Optics letters·2009
Same author

Measuring angles on digitalized radiographic images using Microsoft PowerPoint.

The West Indian medical journal·2009
Same author

Reason for discontinuation of newly prescribed antihypertensive medications: methods of a pilot study using computerized patient records.

Pharmacoepidemiology and drug safety·2008
Same author

The Institute of Medicine's report on drug safety: constructive and ambitious, but does it go far enough?

Clinical pharmacology and therapeutics·2007
Same author

Mortality of patients following hip fractures in Barbados.

The West Indian medical journal·2004

Pharmacogenetics and pharmacoepidemiology research offers short-term identification of disease risks and long-term genomic insights. Ethical considerations for tissue databanks and genetic privacy are crucial for responsible research.

Area of Science:

  • Pharmacogenetics
  • Pharmacoepidemiology
  • Genomics

Background:

  • Research in pharmacogenetics and pharmacoepidemiology presents new possibilities.
  • Ethical responsibilities concerning tissue databanks linked to population data require careful consideration.

Purpose of the Study:

  • To explore short- and long-term implications of pharmacogenetics and pharmacoepidemiology research.
  • To identify potential tissue databanks integrated with population data.
  • To summarize ethical obligations in genetic research.

Main Methods:

  • Review of existing data resources for tissue specimens linked to clinical data (e.g., clinical trials, population samples).
  • Consideration of ethical challenges, including privacy and confidentiality of genetic information.

Related Experiment Videos

  • Summary of National Bioethics Advisory Commission report on serum and tissue data banks.

    • Main Results:

    • Short-term: Potential to identify disorders, risk factors for adverse drug events, and target populations.
    • Long-term: Integration of genomics into population data to map genetic risk factors for diseases and drug responses.
    • Ethical issues include privacy, confidentiality breaches, and risks to genetically identifiable groups.

    Conclusions:

    • Pharmacogenetics research, as a component of pharmacoepidemiology, necessitates clear guidelines.
    • Addressing social, methodological, and ethical issues is vital.
    • Broad educational efforts are needed to navigate the complexities of genetic research and data banking.